Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-21-141263
Filing Date
2021-04-29
Accepted
2021-04-29 18:17:24
Documents
6
Effectiveness Date
2021-04-29

Document Format Files

Seq Description Document Type Size
1 S-1MEF d160351ds1mef.htm S-1MEF 34316
2 EX-5.1 d160351dex51.htm EX-5.1 9187
3 EX-23.1 d160351dex231.htm EX-23.1 1542
4 GRAPHIC g160351dsp05.jpg GRAPHIC 2250
5 GRAPHIC g160351dsp05a.jpg GRAPHIC 2795
6 GRAPHIC g160351dsp05b.jpg GRAPHIC 8071
  Complete submission text file 0001193125-21-141263.txt   64610
Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

EIN.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-255627 | Film No.: 21872670
SIC: 2834 Pharmaceutical Preparations